BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29567200)

  • 1. The MEK5/ERK5 mitogen-activated protein kinase cascade is an effector pathway of bone-sustaining bisphosphonates that regulates osteogenic differentiation and mineralization.
    Adam C; Glück L; Ebert R; Goebeler M; Jakob F; Schmidt M
    Bone; 2018 Jun; 111():49-58. PubMed ID: 29567200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERK5 activation is essential for osteoclast differentiation.
    Amano S; Chang YT; Fukui Y
    PLoS One; 2015; 10(4):e0125054. PubMed ID: 25885811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP promotes myogenic differentiation
    Chen TH; Chen CY; Wen HC; Chang CC; Wang HD; Chuu CP; Chang CH
    FASEB J; 2017 Jul; 31(7):2963-2972. PubMed ID: 28356344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1.
    Komaravolu RK; Adam C; Moonen JR; Harmsen MC; Goebeler M; Schmidt M
    Cardiovasc Res; 2015 Jan; 105(1):86-95. PubMed ID: 25388666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ERK5 and ERK1/2 signaling pathways play opposing regulatory roles during chondrogenesis of adult human bone marrow-derived multipotent progenitor cells.
    Bobick BE; Matsche AI; Chen FH; Tuan RS
    J Cell Physiol; 2010 Jul; 224(1):178-86. PubMed ID: 20232315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development.
    Nishimoto S; Kusakabe M; Nishida E
    EMBO Rep; 2005 Nov; 6(11):1064-9. PubMed ID: 16179948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells.
    Clark PR; Jensen TJ; Kluger MS; Morelock M; Hanidu A; Qi Z; Tatake RJ; Pober JS
    Microcirculation; 2011 Feb; 18(2):102-17. PubMed ID: 21166929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1.
    Takeda AN; Oberoi-Khanuja TK; Glatz G; Schulenburg K; Scholz RP; Carpy A; Macek B; Remenyi A; Rajalingam K
    EMBO J; 2014 Aug; 33(16):1784-801. PubMed ID: 24975362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
    Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
    Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MEK5/ERK5 pathway mediates fluid shear stress promoted osteoblast differentiation.
    Zhao LG; Chen SL; Teng YJ; An LP; Wang J; Ma JL; Xia YY
    Connect Tissue Res; 2014 Apr; 55(2):96-102. PubMed ID: 24111522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
    Cristea S; Coles GL; Hornburg D; Gershkovitz M; Arand J; Cao S; Sen T; Williamson SC; Kim JW; Drainas AP; He A; Cam LL; Byers LA; Snyder MP; Contrepois K; Sage J
    Cancer Res; 2020 Mar; 80(6):1293-1303. PubMed ID: 31969375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of SLC41A1 magnesium transporter promotes mineralization and attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells.
    Tsao YT; Shih YY; Liu YA; Liu YS; Lee OK
    Stem Cell Res Ther; 2017 Feb; 8(1):39. PubMed ID: 28222767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEK5 suppresses osteoblastic differentiation.
    Kaneshiro S; Otsuki D; Yoshida K; Yoshikawa H; Higuchi C
    Biochem Biophys Res Commun; 2015 Jul; 463(3):241-7. PubMed ID: 25998381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis.
    Sohn SJ; Lewis GM; Winoto A
    EMBO J; 2008 Jul; 27(13):1896-906. PubMed ID: 18548009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4).
    Ohnesorge N; Viemann D; Schmidt N; Czymai T; Spiering D; Schmolke M; Ludwig S; Roth J; Goebeler M; Schmidt M
    J Biol Chem; 2010 Aug; 285(34):26199-210. PubMed ID: 20551324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MEK5/ERK5 Pathway in Health and Disease.
    Paudel R; Fusi L; Schmidt M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation.
    Raviv Z; Kalie E; Seger R
    J Cell Sci; 2004 Apr; 117(Pt 9):1773-84. PubMed ID: 15075238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation.
    Nakamura K; Uhlik MT; Johnson NL; Hahn KM; Johnson GL
    Mol Cell Biol; 2006 Mar; 26(6):2065-79. PubMed ID: 16507987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
    Simões AE; Rodrigues CM; Borralho PM
    Drug Discov Today; 2016 Oct; 21(10):1654-1663. PubMed ID: 27320690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R-MEK5-Erk5 Pathway.
    Benito-Jardón L; Díaz-Martínez M; Arellano-Sánchez N; Vaquero-Morales P; Esparís-Ogando A; Teixidó J
    Cancer Res; 2019 May; 79(9):2244-2256. PubMed ID: 30833419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.